Clin2
NCT03713203Possibly a fitRecruiting

Light-based treatment for vulvar Paget’s disease

Paget Disease of the VulvaPaget Disease, Extramammary

Part of Cancer clinical trials.

This study tests a special light treatment (photodynamic therapy) for non-invasive Paget’s disease on the vulva that has come back after surgery. It may help by treating remaining abnormal skin cells where surgery may not remove everything.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have non-invasive vulvar Paget’s disease, either new or coming back after surgery
  • Your recurrence was confirmed by a biopsy within the past year
  • You can understand the study and give written consent
  • You can follow the study rules and attend follow-up visits
  • If you could become pregnant, you can use effective contraception during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03564483Recruiting
Study for vulvar or anal skin cancer called EMPD

This study is for women with a specific rare skin cancer called extramammary Paget’s disease (EMPD) in the vulvar or perianal area. The goal is to better understand the condition and test an approach for people with primary or returning (recurrent) disease in those locations.

Rochester, Minnesota
NCT04161664Recruiting· Phase 2
Chemo for metastatic vulvar cancer with carboplatin and paclitaxel

This trial studies how well carboplatin plus paclitaxel chemotherapy works for vulvar squamous cell cancer that has spread. It may help shrink tumors and control cancer growth in people who are not able to be fully treated with local surgery.

Amsterdam
NCT06873815Recruiting· Phase 2
Using a dye to help see cancer during vulvectomy for Paget's disease

This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.

Basking Ridge, New Jersey
NCT06982976Recruiting
Light therapy for abnormal cervical or vaginal cells

This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.

Beijing, Beijing Municipality
NCT07306247Not yet recruiting
Light therapy for low-grade cervical HPV 16/18

This trial tests a light-activated drug (ALA-PDT) to treat low-grade cervical changes caused by HPV 16 or 18. It may help clear the virus and prevent progression to more serious disease.

Hangzhou, Zhejiang
NCT06311890Recruiting· Phase 2
Light therapy for moderate to severe acne

This trial tests a light-activated therapy (called photodynamic therapy) using a special gel that is put on the skin and then activated with a light to treat moderate to severe acne. It may help people who have not responded well to other treatments.

Beijing

Hear when a new Paget Disease, Extramammary trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.